This CME/NCPD online activity will provide expert perspectives and guidance on the evolving role of immunotherapy in comprehensive care plans for patients with recurrent/metastatic HNSCC. To reinforce knowledge retention and expand the reach and distribution of the educational content to the broader oncology provider audience, a CME/NCPD-approved play at home enduring event archive will be accessible via the i3 Health website and mobile app.
- Provider:i3 Health
- Activity Link: https://i3health.com/course-information/hnscc-harnessing-immunotherapy-in-comprehensive-care
- Start Date: 2024-04-03 05:00:00
- End Date: 2024-04-03 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Merck (Any division) - Amount: 96575.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest